Announcements Trials
Browse Landscape

Phase

Phase NA 12Phase 1 4Phase 4 3Phase 3 3Phase 2 3Phase 2/3 1Phase 1/2 1

Status

Unknown 3Recruiting 3Completed 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 53Carcinoma, Hepatocellular 40Neoplasms 38Polycystic Ovary Syndrome 27Colorectal Neoplasms 24Stomach Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Carcinoma, Non-Small-Cell Lung 17Prostatic Neoplasms 15Recurrence 13Pancreatic Neoplasms 13Lymphoma 13Liver Neoplasms 12Urinary Bladder Neoplasms 11Leukemia, Myeloid, Acute 11Esophageal Neoplasms 11Leiomyoma 10Colonic Neoplasms 10Pain 9Lung Neoplasms 9Multiple Myeloma 8Uterine Cervical Neoplasms 7Neoplasm Metastasis 7Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 7Keratosis, Actinic 7Infertility 7Papillomavirus Infections 6Pain, Postoperative 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6

Interventions

tislelizumab 1lornoxicam 1Ofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Non-Muscle Invasive Bladder Neoplasms × Clear all
NCT05580354 2022-10-14

Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer

Ruijin Hospital

Phase 4 Unknown
42 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT03221062 2017-07-21

"En Bloc" Resection of NMIBC: a Prospective, Single Centre,Randomized Study

Tongji Hospital

Phase 4 Unknown
180 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT03038321 2017-05-23

Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?

Mansoura University

Phase 4 Unknown
150 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Cystitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡